查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1916511

全球DNA定序市场：市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的分析及预测（2026-2034）

DNA Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

DNA定序市场成长驱动因素

全球DNA定序市场是现代基因组学的关键基础，能够精确识别核酸序列，用于疾病诊断、药物研发、个人化医疗、法医学和演化研究。 DNA定序技术已从第一代桑格定序发展到下一代定序（NGS）和先进的第三代定序（TGS）平台，这些平台具有高通量、长读长和高精度等优势。这些进步拓展了定序的应用范围，包括临床诊断、肿瘤学、罕见疾病检测和群体基因体学研究。

DNA定序市场规模及价值

根据市场报告显示，2025年全球DNA定序市场规模为123.1亿美元。预计到2026年，在诊断和实验室中测序技术日益普及的推动下，该市场规模将增长至133.6亿美元。在预测期内，预计到2034年，该市场规模将达到272.5亿美元，反映了定序技术快速融入常规临床工作流程和药物研发流程。预计2026年至2034年，该市场将以9.32%的复合年增长率成长，这主要得益于技术创新、监管批准以及基因组数据临床应用价值的不断提升。

推动市场成长的因素

全基因组定序（WGS）在临床诊断中的日益普及是推动市场成长的关键因素。全基因组定序 (WGS) 能够全面检测传统方法难以发现的基因突变，从而支持早期诊断和标靶治疗的选择。随着遗传性疾病和癌症发生率的上升，人们越来越依赖基因组分析进行治疗方案製定。

定序资料在药物发现和生物标记识别的应用日益广泛，进一步推动了市场需求。製药公司越来越依赖基因组数据集进行患者分层、临床试验优化和治疗标靶识别。公共和私人对基因组基础设施、国家基因组图谱规划以及对基于二代测序 (NGS) 的诊断技术的监管支持的投资，正在加速其在临床实践中的应用。

市场限制因素与挑战

一个关键的限制因素是全球基因组学和生物资讯学领域熟练专家的短缺。解读定序资料需要专门的计算技能，这限制了其在资源有限的医疗保健系统中的应用。定序错误、假阳性以及重复基因组区域检测不足等技术挑战也会影响诊断的可靠性。

基因组资讯高度敏感，因此资料安全和隐私问题仍然是重大挑战。缺乏标准化的全球基因组数据处理和跨境研究合作监管框架，进一步阻碍了市场扩张，尤其是在新兴经济体。

市场趋势与技术进步

第三代定序平台发展势头强劲，这得益于其生成长读长的能力，从而能够准确检测结构突变和表观遗传修饰。奈米孔定序和单分子即时定序技术正越来越多地应用于癌症研究、罕见疾病诊断和微生物组分析。

将人工智慧 (AI) 和机器学习应用于资料解读正成为一大趋势，帮助实验室更有效率地分析大量资料集。基于云端的生物资讯平台也在改善研究机构间的资料储存、存取和协作。

液体活检测序透过检测循环肿瘤DNA实现非侵入性癌症监测，有助于早期发现并改善治疗追踪。

依产品/服务划分的市场区隔

依产品/服务划分，市场分为产品与软体/服务两部分。产品部分主要受定序仪、流动池和试剂盒的高需求驱动，预计2026年将占据63.29%的市场。由于定序工作流程的重复采购週期，耗材预计将快速成长。

软体/服务部分呈现显着成长，这主要得益于定序服务外包的增加，尤其是在临床和药物研究领域，以及对生物资讯解决方案日益增长的需求。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要疾病流行情形（2025 年）
  • DNA 定序技术进展
  • 概述：DNA 定序新兴趋势
  • 主要公司新产品发布及核准状况
  • 主要产业趋势：併购、收购等等。
  • 新冠疫情对市场的影响

第五章 全球DNA定序市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品/服务划分
    • 产品
      • 设备
      • 耗材
    • 软体/服务
  • 市场分析、洞察与预测：依技术划分
    • 桑格定序
    • 次世代定序
    • 第三代定序
  • 市场分析、洞察与预测：依类型划分
    • 全基因组/外显子定序
    • 表观遗传学
    • 标靶定序感测
    • 宏基因体学
    • 其他
  • 市场分析、洞察与预测：依应用领域划分
    • 药物发现与开发
    • 诊断
    • 个人化医疗
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 生技和製药公司
    • 诊断中心
    • 学术和研究机构
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美DNA定序市场分析：洞察与预测 （2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲DNA定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章：亚太地区DNA定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 东南亚亚洲
    • 其他亚太地区

第九章：拉丁美洲DNA定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲DNA定序市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司型材
    • Illumina 公司
    • 赛默飞世尔科技公司
    • 牛津奈米孔技术有限公司。
    • 太平洋生物
    • 凯杰
    • 珀金埃尔默公司
    • Azenta 美国公司
    • 华大基因
Product Code: FBI101527

Growth Factors of DNA sequencing Market

The global DNA sequencing market is a fundamental pillar of modern genomics, enabling precise identification of nucleotide sequences for disease diagnosis, drug development, personalized medicine, forensic science, and evolutionary research. DNA sequencing technologies have transitioned from first-generation Sanger sequencing to high-throughput Next-Generation Sequencing (NGS) and advanced Third-Generation Sequencing (TGS) platforms, offering rapid processing, long-read capabilities, and enhanced accuracy. These advancements have expanded sequencing applications across clinical diagnostics, oncology, rare disease detection, and population-scale genomics initiatives.

DNA Sequencing Market Size and Market Value

As per the market report, the global DNA sequencing market size was valued at USD 12.31 billion in 2025. The market is projected to grow to USD 13.36 billion in 2026, supported by rising adoption of sequencing technologies in diagnostics and research laboratories. Over the forecast period, the market is expected to reach a market value of USD 27.25 billion by 2034, reflecting rapid integration of sequencing into routine clinical workflows and pharmaceutical research pipelines. The market is projected to expand at a CAGR of 9.32% from 2026 to 2034, driven by technological innovation, regulatory approvals, and expanding clinical utility of genomic data.

Market Drivers Supporting Growth

The growing adoption of Whole Genome Sequencing (WGS) in clinical diagnostics is a major growth driver. WGS enables comprehensive detection of genetic variations that traditional methods often fail to identify, supporting early diagnosis and targeted therapy selection. Rising prevalence of genetic disorders and cancer is increasing reliance on genomic profiling for treatment planning.

Expanding use of sequencing data in drug discovery and biomarker identification is further driving demand. Pharmaceutical companies increasingly rely on genomic datasets for patient stratification, clinical trial optimization, and identification of therapeutic targets. Public and private investments in genomics infrastructure, national genome mapping programs, and regulatory support for NGS-based diagnostics are accelerating clinical integration.

Market Restraints and Challenges

A major restraint is the global shortage of skilled professionals in genomics and bioinformatics. Interpreting sequencing data requires specialized computational expertise, limiting adoption in resource-constrained healthcare systems. Technical challenges such as sequencing errors, false positives, and limitations in detecting repetitive genomic regions also affect diagnostic reliability.

Data security and privacy concerns remain critical, as genomic information is highly sensitive. Lack of standardized global regulatory frameworks for genomic data handling and cross-border research collaborations further complicates market expansion, especially in emerging economies.

Market Trends and Technological Advancements

Third-Generation Sequencing platforms are gaining strong momentum due to their ability to generate long reads, enabling accurate detection of structural variants and epigenetic modifications. Nanopore and Single-Molecule Real-Time sequencing are increasingly adopted in cancer research, rare disease diagnostics, and microbiome analysis.

Integration of artificial intelligence and machine learning in data interpretation is becoming a major trend, helping laboratories analyze massive datasets more efficiently. Cloud-based bioinformatics platforms are also improving data storage, accessibility, and collaboration across research institutions.

Liquid biopsy sequencing is gaining traction for non-invasive cancer monitoring by detecting circulating tumor DNA, improving early detection and treatment monitoring.

Segmentation Analysis by Products and Services

By products and services, the market is divided into products and software & services. The products segment dominated the market with a 63.29% share in 2026, driven by high demand for sequencing instruments, flow cells, and reagent kits. Consumables are expected to grow rapidly due to repeat purchase cycles associated with sequencing workflows.

The software and services segment is witnessing strong growth due to increasing outsourcing of sequencing services and demand for bioinformatics solutions, particularly in clinical and pharmaceutical research settings.

Segmentation by Technique and Type

By technique, Next-Generation Sequencing held the largest market share and is projected to capture 85.99% share in 2026, driven by its cost efficiency, scalability, and compatibility with multiple clinical applications. Third-Generation Sequencing is growing at the fastest pace due to long-read sequencing advantages, while Sanger sequencing remains relevant for validation and small-scale research.

By type, targeted sequencing dominated in 2024 due to its widespread use in oncology diagnostics. Whole genome and whole exome sequencing is expanding rapidly, with an estimated 45.98% market share in 2026, driven by rare disease diagnostics and population genomics studies. Epigenomics is growing rapidly due to rising cancer research applications.

Segmentation by Application and End User

By application, diagnostics leads the market, supported by growing cancer screening programs and genetic disorder testing. Drug discovery and development represents the second-largest segment, driven by genomics-guided clinical trials and biomarker research.

By end user, diagnostic centers dominate due to increasing adoption of NGS in oncology and prenatal screening. Academic and research institutes remain strong contributors through large-scale genome projects, while biotechnology and pharmaceutical companies continue expanding internal sequencing capabilities.

Regional Outlook

North America dominated the DNA sequencing market with USD 5.74 billion in 2025 and USD 6.21 billion in 2026, supported by advanced research infrastructure, strong reimbursement systems, and large multi-omics programs. The U.S. remains the largest national market due to extensive clinical sequencing adoption and biotechnology investments.

Europe follows with strong government funding, national genome initiatives, and rising cancer prevalence. Asia Pacific is the fastest-growing region due to expanding healthcare investments, government genomics programs, and domestic manufacturing partnerships in China, Japan, and India. Latin America and the Middle East & Africa are witnessing gradual growth supported by expanding diagnostic infrastructure.

Competitive Landscape

Major companies operating in the DNA sequencing market include Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, PacBio, QIAGEN, PerkinElmer, Azenta, and BGI Genomics. These players focus on new platform launches, bioinformatics integration, geographic expansion, and strategic collaborations with healthcare and research institutions. Investments in long-read sequencing, automation, and AI-driven analytics remain central to competitive differentiation.

Conclusion

The DNA sequencing market is experiencing strong and sustained growth, driven by rapid technological advancements, expanding clinical applications, and increasing integration of genomics into routine healthcare and pharmaceutical research. With the market valued at USD 12.31 billion in 2025, projected to reach USD 13.36 billion in 2026, and expected to expand to USD 27.25 billion by 2034, the industry reflects robust long-term potential. Rising adoption of whole genome and targeted sequencing in oncology, rare disease diagnosis, and personalized medicine, along with growing use in drug discovery and biomarker development, is strengthening market demand. Although challenges such as shortage of skilled professionals, data interpretation complexity, and privacy concerns persist, continuous innovation in next-generation and third-generation sequencing platforms, integration of AI-driven bioinformatics, and expanding government-supported genomics initiatives are expected to further accelerate market adoption across developed and emerging regions.

Segmentation By Products & Services

  • Products
    • Equipment
    • Consumables
  • Software & Services

By Technique

  • Sanger Sequencing
  • Next-generation Sequencing
  • Third-generation Sequencing

By Type

  • Whole Genome / Exome Sequencing
  • Epigenomics
  • Targeted Sequencing
  • Metagenomics
  • Others

By Application

  • Drug Discovery & Development
  • Diagnostics
  • Personalized Medicine
  • Others

By End-user

  • Biotechnology & Pharmaceutical Companies
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Products & Services, Technique, Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. Technological Advancement in DNA Sequencing
  • 4.3. Overview: Emerging Trends in the DNA Sequencing
  • 4.4. New Product Launches/ Approvals, By Key Players
  • 4.5. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
  • 4.6. Impact of COVID-19 on the Market

5. Global DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Products & Services
    • 5.1.1. Products
      • 5.1.1.1. Equipment
      • 5.1.1.2. Consumables
    • 5.1.2. Software & Services
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Sanger Sequencing
    • 5.2.2. Next-generation Sequencing
    • 5.2.3. Third-generation Sequencing
  • 5.3. Market Analysis, Insights and Forecast - By Type
    • 5.3.1. Whole Genome / Exome Sequencing
    • 5.3.2. Epigenetics
    • 5.3.3. Targeted Sequencing
    • 5.3.4. Metagenomics
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Drug Discovery & Development
    • 5.4.2. Diagnostics
    • 5.4.3. Personalized Medicine
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Biotechnology & Pharmaceutical Companies
    • 5.5.2. Diagnostics Centers
    • 5.5.3. Academic & Research Institutes
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Products & Services
    • 6.1.1. Products
      • 6.1.1.1. Equipment
      • 6.1.1.2. Consumables
    • 6.1.2. Software & Services
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Sanger Sequencing
    • 6.2.2. Next-generation Sequencing
    • 6.2.3. Third-generation Sequencing
  • 6.3. Market Analysis, Insights and Forecast - By Type
    • 6.3.1. Whole Genome / Exome Sequencing
    • 6.3.2. Epigenetics
    • 6.3.3. Targeted Sequencing
    • 6.3.4. Metagenomics
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Drug Discovery & Development
    • 6.4.2. Diagnostics
    • 6.4.3. Personalized Medicine
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Biotechnology & Pharmaceutical Companies
    • 6.5.2. Diagnostics Centers
    • 6.5.3. Academic & Research Institutes
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Products & Services
    • 7.1.1. Products
      • 7.1.1.1. Equipment
      • 7.1.1.2. Consumables
    • 7.1.2. Software & Services
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Sanger Sequencing
    • 7.2.2. Next-generation Sequencing
    • 7.2.3. Third-generation Sequencing
  • 7.3. Market Analysis, Insights and Forecast - By Type
    • 7.3.1. Whole Genome / Exome Sequencing
    • 7.3.2. Epigenetics
    • 7.3.3. Targeted Sequencing
    • 7.3.4. Metagenomics
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Drug Discovery & Development
    • 7.4.2. Diagnostics
    • 7.4.3. Personalized Medicine
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Biotechnology & Pharmaceutical Companies
    • 7.5.2. Diagnostics Centers
    • 7.5.3. Academic & Research Institutes
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Products & Services
    • 8.1.1. Products
      • 8.1.1.1. Equipment
      • 8.1.1.2. Consumables
    • 8.1.2. Software & Services
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Sanger Sequencing
    • 8.2.2. Next-generation Sequencing
    • 8.2.3. Third-generation Sequencing
  • 8.3. Market Analysis, Insights and Forecast - By Type
    • 8.3.1. Whole Genome / Exome Sequencing
    • 8.3.2. Epigenetics
    • 8.3.3. Targeted Sequencing
    • 8.3.4. Metagenomics
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Drug Discovery & Development
    • 8.4.2. Diagnostics
    • 8.4.3. Personalized Medicine
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Biotechnology & Pharmaceutical Companies
    • 8.5.2. Diagnostics Centers
    • 8.5.3. Academic & Research Institutes
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Products & Services
    • 9.1.1. Products
      • 9.1.1.1. Equipment
      • 9.1.1.2. Consumables
    • 9.1.2. Software & Services
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Sanger Sequencing
    • 9.2.2. Next-generation Sequencing
    • 9.2.3. Third-generation Sequencing
  • 9.3. Market Analysis, Insights and Forecast - By Type
    • 9.3.1. Whole Genome / Exome Sequencing
    • 9.3.2. Epigenetics
    • 9.3.3. Targeted Sequencing
    • 9.3.4. Metagenomics
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Drug Discovery & Development
    • 9.4.2. Diagnostics
    • 9.4.3. Personalized Medicine
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Biotechnology & Pharmaceutical Companies
    • 9.5.2. Diagnostics Centers
    • 9.5.3. Academic & Research Institutes
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Products & Services
    • 10.1.1. Products
      • 10.1.1.1. Equipment
      • 10.1.1.2. Consumables
    • 10.1.2. Software & Services
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Sanger Sequencing
    • 10.2.2. Next-generation Sequencing
    • 10.2.3. Third-generation Sequencing
  • 10.3. Market Analysis, Insights and Forecast - By Type
    • 10.3.1. Whole Genome / Exome Sequencing
    • 10.3.2. Epigenetics
    • 10.3.3. Targeted Sequencing
    • 10.3.4. Metagenomics
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Drug Discovery & Development
    • 10.4.2. Diagnostics
    • 10.4.3. Personalized Medicine
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Biotechnology & Pharmaceutical Companies
    • 10.5.2. Diagnostics Centers
    • 10.5.3. Academic & Research Institutes
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Oxford Nanopore Technologies plc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. PacBio
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. QIAGEN
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. PerkinElmer Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Azenta US, Inc,
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. BGI Genomics
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 2: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Technique 2021-2034
  • Table 4: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 5: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global DNA Sequencing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 7: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Region 2021-2034
  • Table 8: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 9: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 11: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 15: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 16: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 17: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 18: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 19: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 21: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 23: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 24: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 25: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 29: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 30: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 31: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 32: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 33: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 35: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
  • Table 37: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 38: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 39: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 40: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global DNA Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 3: Global DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 4: Global DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 5: Global DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global DNA Sequencing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 9: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 10: North America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 11: North America DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 12: North America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 13: North America DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 14: North America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 15: North America DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 16: North America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 17: North America DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 18: North America DNA Sequencing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America DNA Sequencing Market Value Share (%), By Country, 2025
  • Figure 20: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 21: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 22: Europe DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 23: Europe DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 24: Europe DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 25: Europe DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 26: Europe DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 27: Europe DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 28: Europe DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 29: Europe DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 30: Europe DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 33: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 34: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 35: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 36: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 37: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 38: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 39: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 45: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 46: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 47: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 48: Latin America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 49: Latin America DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 50: Latin America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 51: Latin America DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 52: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 53: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
  • Figure 57: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025
  • Figure 58: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 59: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025
  • Figure 60: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
  • Figure 61: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025
  • Figure 62: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global DNA Sequencing Market Share (%), By Company, 2025